Literature DB >> 23433427

The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles.

Manuela Budoni1, Alessandra Fierabracci, Rosa Luciano, Stefania Petrini, Vincenzo Di Ciommo, Maurizio Muraca.   

Abstract

The immunomodulatory properties of mesenchymal stromal cells are the subject of increasing interest and of widening clinical applications, but the reproducibility of their effects is controversial and the underlying mechanisms have not been fully clarified. We investigated the transfer of membrane vesicles, a recently recognized pathway of intercellular communication, as possible mediator of the interaction between mesenchymal stromal cells and B lymphocytes. Mesenchymal stromal cells exhibited a strong dose-dependent inhibition of B-cell proliferation and differentiation in a CpG-stimulated peripheral blood mononuclear cell coculture system. We observed that these effects could be fully reproduced by membrane vesicles isolated from mesenchymal stromal cell culture supernatants in a dose-dependent fashion. Next, we evaluated the localization of fluorescently labeled membrane vesicles within specific cell subtypes both by flow cytometry and by confocal microscopy analysis. Membrane vesicles were found to be associated with stimulated B lymphocytes, but not with other cell phenotypes (T lymphocytes, dendritic cells, natural killer cells), in peripheral blood mononuclear cell culture. These results suggest that membrane vesicles derived from mesenchymal stromal cells are the conveyors of the immunosuppressive effect on B lymphocytes. These particles should be further evaluated as immunosuppressive agents in place of the parent cells, with possible advantages in term of standardization, safety, and feasibility.

Mesh:

Year:  2013        PMID: 23433427     DOI: 10.3727/096368911X582769

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  61 in total

Review 1.  MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.

Authors:  Konstantinos Sdrimas; Stella Kourembanas
Journal:  Antioxid Redox Signal       Date:  2014-02-24       Impact factor: 8.401

Review 2.  Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.

Authors:  Airan Liu; Xiwen Zhang; Hongli He; Li Zhou; Yoshifumi Naito; Shinji Sugita; Jae-Woo Lee
Journal:  Expert Opin Biol Ther       Date:  2019-11-18       Impact factor: 4.388

3.  Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.

Authors:  Basile Stamatopoulos; Michaël Van Damme; Emerence Crompot; Barbara Dessars; Hakim El Housni; Philippe Mineur; Nathalie Meuleman; Dominique Bron; Laurence Lagneaux
Journal:  Mol Med       Date:  2015-01-09       Impact factor: 6.354

Review 4.  Exosomes in perspective: a potential surrogate for stem cell therapy.

Authors:  Ke Ren
Journal:  Odontology       Date:  2018-10-15       Impact factor: 2.634

5.  Interferon-γ alters the immune-related miRNA expression of microvesicles derived from mesenchymal stem cells.

Authors:  Ai-Qi Zhao; Hui Xie; Sheng-Yan Lin; Qian Lei; Wen-Xiang Ren; Fei Gao; Hao Guo; An-Yuan Guo; Zhi-Chao Chen; Hong-Xiang Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-04-11

6.  Human Wharton's Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses.

Authors:  Mohamed A A Hussein; Hosni A M Hussein; Ali A Thabet; Karim M Selim; Mervat A Dawood; Ahmed M El-Adly; Ahmed A Wardany; Ali Sobhy; Sameh Magdeldin; Aya Osama; Ali M Anwar; Mohammed Abdel-Wahab; Hussam Askar; Elsayed K Bakhiet; Serageldeen Sultan; Amgad A Ezzat; Usama Abdel Raouf; Magdy M Afifi
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

Review 7.  Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.

Authors:  Akram Hoseinzadeh; Zahra Rezaieyazdi; Jalil Tavakol Afshari; Ali Mahmoudi; Sahar Heydari; Reza Moradi; Seyed-Alireza Esmaeili; Mahmoud Mahmoudi
Journal:  Stem Cell Rev Rep       Date:  2022-10-22       Impact factor: 6.692

8.  Alveolar Epithelial Cell-Derived Prostaglandin E2 Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation.

Authors:  Jennifer M Speth; Emilie Bourdonnay; Loka Raghu Kumar Penke; Peter Mancuso; Bethany B Moore; Jason B Weinberg; Marc Peters-Golden
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

Review 9.  Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges.

Authors:  S Alex Mitsialis; Stella Kourembanas
Journal:  Semin Perinatol       Date:  2016-01-15       Impact factor: 3.300

Review 10.  Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair.

Authors:  Si-Jia Sun; Rui Wei; Fei Li; Song-Yan Liao; Hung-Fat Tse
Journal:  Stem Cell Reports       Date:  2021-06-10       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.